Targeted Genetics Corporation (NASDAQ:TGEN) to Hold Q4 2007 Earnings March 25

Targeted Genetics Corporation (NASDAQ:TGEN) will hold a conference call on Tuesday, March 25 at 10:30 am to discuss the fourth quarter earnings for 2007.

A clinical-stage biotechnology company, Targeted Genetics conducts research and develops gene therapy products to treat acquired and inherited diseases.  These programs are developed by the company and under collaborative agreements with other companies.

The company also developed several product candidates, as of December 31, 2006.  Two of their candidates are in clinical trials and are geared towards treating inflammatory arthritis and human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS).

The company’s preclinical and clinical candidates are focused on congestive heart failure and Huntingons disease.

Targeted Genetics Corporation (NASDAQ:TGEN)

To view more Conference Call related events or to post your own events, visit:

http://events.finditt.com/Events_List.aspx?catid=12